Fosamax Cost in Oregon 2026: What You'll Actually Pay for Alendronate

What Is Alendronate and Why Oregon Patients Use It

Alendronate is a nitrogen-containing bisphosphonate that suppresses osteoclast-mediated bone resorption, slowing bone loss and reducing fracture risk. The FDA approved alendronate sodium (Fosamax) for postmenopausal osteoporosis treatment in 1995, and the generic has been available since 2008, driving prices down sharply. FDA Fosamax approval and labeling.

The Fracture Intervention Trial (FIT), published in JAMA 1998 (N=2,027 women with low bone density), found that alendronate reduced the risk of new vertebral fractures by 47% (relative risk 0.53 to 95% CI 0.41-0.68) compared with placebo over three years [1]. Hip fracture risk fell by 51% in the subset with confirmed osteoporosis at baseline. Those numbers explain why alendronate remains a first-line agent in both the American Association of Clinical Endocrinologists (AACE) 2020 osteoporosis guidelines and the Endocrine Society's 2019 pharmacological management recommendations [2][3].

Oregon has roughly 620,000 residents aged 65 or older as of 2024 census estimates, a population with elevated osteoporosis prevalence. The National Osteoporosis Foundation estimates that 10.2 million Americans have osteoporosis and another 43.4 million have low bone mass, giving Oregon an estimated 270,000 to 300,000 people who might benefit from bisphosphonate therapy [4]. Knowing the actual local cost matters for adherence. A 2016 study in Osteoporosis International found that out-of-pocket costs above $30 per month were independently associated with 32% lower medication adherence in bisphosphonate users, a clinically meaningful gap given that adherence drives fracture prevention [5].

How Much Does Alendronate Actually Cost at Oregon Pharmacies in 2026

Generic alendronate 70 mg (four tablets, one month supply) runs approximately $12 to $18 at most Oregon retail pharmacies in 2026 when purchased with a discount card. Brand Fosamax carries a Merck list price near $80 per month, but paying that list price is rare.

The price variation across channels is substantial:

GoodRx and discount cards. GoodRx prices in Oregon for a 4-tablet (28-day) supply of generic alendronate 70 mg sit between $12 and $22 depending on the pharmacy chain. Fred Meyer, Costco, and Walmart pharmacies in Portland and Eugene tend to cluster at the lower end of that range. Rite Aid and some independent pharmacies may price slightly higher. Always compare same-day GoodRx quotes because contracts update frequently [6].

Manufacturer savings program. Merck offers a savings card for brand Fosamax for commercially insured patients, which can lower copays to as little as $0 to $10 per fill. Oregon residents on Medicaid or Medicare Part D are not eligible for manufacturer cards under federal anti-kickback rules. The Merck patient assistance program (MAP) may cover uninsured patients with household incomes at or below 400% of the federal poverty level [7].

340B pricing. Oregon federally qualified health centers (FQHCs) and rural health clinics participate in the 340B drug pricing program. Patients who receive care at a 340B-eligible site may access alendronate at deeply discounted institutional prices, sometimes below $5 per month. HRSA maintains the 340B covered entity database at hrsa.gov [8].

Medicare Part D. Alendronate sits on Tier 1 (preferred generic) of most Part D formularies. The 2024 Inflation Reduction Act changes cap Medicare out-of-pocket drug costs at $2,000 per year starting in 2025, and a $2,000 annual cap effectively eliminates meaningful cost exposure for a drug priced at $15 per month. Beneficiaries in the low-income subsidy (Extra Help) program typically pay $0 to $4 per fill [9].

Cash pay without insurance. Without any card or program, a 30-day supply of generic alendronate 70 mg at most Oregon pharmacies lists between $30 and $80, which is why presenting a GoodRx or RxSaver coupon at the counter is worth the 30 seconds it takes.

Oregon Medicaid (Oregon Health Plan) Coverage for Alendronate

Oregon Health Plan (OHP) covers alendronate on its Preferred Drug List (PDL) for members with a documented diagnosis of osteoporosis or osteopenia meeting defined criteria, subject to prior authorization (PA).

The Oregon Health Authority Pharmacy and Therapeutics (P and T) Committee places generic alendronate sodium in the bisphosphonates therapeutic class. PA requirements as of 2025 to 2026 typically ask for:

1. A dual-energy X-ray absorptiometry (DXA) scan confirming T-score at or below -2.5 (osteoporosis) or T-score between -1.0 and -2.5 with a FRAX 10-year major osteoporotic fracture risk at or above 20%.
2. Documentation that the prescriber has reviewed fracture risk and calcium or vitamin D status.
3. For secondary osteoporosis indications (glucocorticoid-induced, male osteoporosis), additional chart documentation may be required.

The PA turnaround under OHP Coordinated Care Organizations (CCOs) is typically 72 hours for standard requests and 24 hours for expedited urgent requests per Oregon state managed care rules [10]. Once approved, refill authorization usually covers 12 months before requiring renewal.

OHP members who are denied coverage may request a formal appeal within 60 days of the notice. The Oregon Health Authority's Office of Administrative Hearings handles those appeals. Members can also ask their prescriber to submit a medical exception if a non-preferred agent or compounded formulation is medically necessary.

Patients on OHP who meet PA criteria pay $0 to $3 per fill at network pharmacies, making alendronate one of the lowest-cost osteoporosis medications available to low-income Oregonians. The Endocrine Society's 2019 guideline explicitly states: "Alendronate and risedronate are the preferred first-line agents for most patients with osteoporosis due to their established fracture-reduction evidence and low cost" [3].

Which Private Insurance Plans Cover Fosamax or Alendronate in Oregon

Most commercial insurance plans sold through Cover Oregon and off-exchange include generic alendronate on their formularies. Tier placement varies:

• Tier 1 (preferred generic): Kaiser Permanente Northwest, PacificSource, and most Providence Health Plan individual and small-group products list generic alendronate here, producing copays of $0 to $10.
• Tier 2 (non-preferred generic): Some Moda Health and Regence plans place it here, producing copays of $10 to $30.
• Brand Fosamax: Consistently placed at Tier 3 or higher across Oregon carriers, with copays of $40 to $100 without a manufacturer card.

Employer-sponsored plans vary by employer. Large Oregon employers (Nike, Intel, Oregon Health and Science University) tend to use PBMs like Express Scripts or CVS Caremark, both of which list alendronate at Tier 1 generics. The Affordable Care Act requires that preventive services rated A or B by the USPSTF be covered without cost sharing. The USPSTF gave screening for osteoporosis in women 65 and older a Grade B recommendation in 2018 [11]. The screening recommendation itself is cost-share-free, but treatment (alendronate) is not classified as a preventive service, so standard formulary cost sharing applies.

If your insurer places alendronate at a tier that makes it expensive, ask your prescriber to submit a step therapy exception or formulary exception. Oregon law (ORS 743B.472) requires insurers to have a clear, timely exception process, with decisions within 72 hours for standard and 24 hours for expedited requests [12].

Is Compounded Alendronate Legal in Oregon

Compounded alendronate is legal in Oregon when prepared by a state-licensed 503A pharmacy operating under a valid patient-specific prescription from a licensed prescriber. 503A pharmacies compound for individual patients and are regulated by the Oregon Board of Pharmacy under ORS Chapter 689 and the federal Drug Quality and Security Act of 2013 [13].

The practical use case for compounded alendronate in Oregon is narrow but real. Some patients experience significant gastrointestinal intolerance to commercial alendronate tablets, including esophageal irritation and reflux, and a compounded formulation (for example, alendronate prepared in a different delivery vehicle or strength) may be medically justified if the prescriber documents the clinical rationale.

The HealthRX clinical team uses the following framework for determining when compounded alendronate is appropriate for Oregon patients:

Step 1. Confirm the patient has a DXA-confirmed diagnosis and a valid prior-authorization from OHP or commercial insurance for standard alendronate. Step 2. Document at least one trial (minimum four weeks) of the commercial 70 mg weekly tablet with GI adverse effects persisting despite proper administration instructions (take with 6 to 8 oz of water, remain upright for 30 minutes, do not eat for at least 30 minutes). Step 3. Evaluate whether IV zoledronic acid (covered by Medicare Part B under J3487) is more appropriate than compounded oral alendronate. Step 4. If compounded oral alendronate is still preferred, write the prescription to a licensed Oregon 503A pharmacy specifying the exact strength, vehicle, and quantity. The pharmacy must source alendronate API from an FDA-registered supplier. Step 5. Confirm cost. Compounded alendronate at 503A Oregon pharmacies may cost $0 to $30 per month depending on the pharmacy and whether OHP or insurance will cover extemporaneous compounding. OHP covers compounded drugs only when no commercially available equivalent meets the patient's documented medical need.

A 503B outsourcing facility (which compounds in bulk without patient-specific prescriptions) cannot legally supply compounded alendronate to individual Oregon patients without a valid prescription; that would constitute dispensing an unapproved drug. The FDA's guidance on 503A and 503B distinctions is available at fda.gov [14].

Can Oregon Patients Get Alendronate via Telehealth

Yes. Oregon law permits telehealth prescribing of alendronate by licensed Oregon prescribers, including physicians, nurse practitioners, and physician assistants. A valid prescriber-patient relationship must be established, which Oregon defines as including a synchronous audio-visual encounter (video visit) or, for established patients, asynchronous review of records in some CCO contexts [15].

Telehealth prescribing of alendronate became fully normalized in Oregon after Senate Bill 1543 (2020) and subsequent Oregon Health Authority telehealth rules (OAR 410-120-1860) confirmed that non-controlled medications may be prescribed via audio-visual telehealth visits. Alendronate is not a controlled substance, so no DEA-specific telehealth waiver is required.

HealthRX and similar telehealth platforms operating in Oregon can prescribe alendronate after a structured clinical assessment that includes:

• Review of DXA results (uploaded by the patient or obtained from the patient's prior provider).
• FRAX score calculation using the patient's bone mineral density, age, weight, height, and clinical risk factors.
• Medication reconciliation to check for interactions (notably calcium supplements should be taken at a different time of day from alendronate to avoid chelation, per the FDA label) [7].
• Follow-up DXA ordered at 24 months per AACE 2020 monitoring intervals [2].

Telehealth visits for osteoporosis assessment at HealthRX are covered by OHP for eligible members and by most Oregon commercial plans under parity rules established by ORS 743A.185. Cash-pay telehealth visits for an initial osteoporosis consultation start at $75 to $150 at most Oregon telehealth platforms.

Practical Ways to Lower Your Alendronate Cost in Oregon Right Now

Several concrete steps can reduce what an Oregon patient pays for alendronate in 2026. No single approach fits every situation, so the right path depends on insurance status.

Uninsured or underinsured patients. Present a GoodRx, RxSaver, or NeedyMeds coupon at a Costco, Fred Meyer, or Walmart pharmacy. Expect to pay $12 to $18 for a 28-day supply of generic alendronate 70 mg. The Merck patient assistance program covers patients with household incomes at or below 400% of the federal poverty level; applications are submitted at merckhelps.com [7].

OHP members. Request that your prescriber submit the prior authorization with DXA documentation attached. Once approved, your cost is $0 to $3 per fill at a network pharmacy. The National Institute on Aging has published detailed guidance on osteoporosis diagnosis standards relevant to PA documentation [16].

Medicare Part D beneficiaries. Confirm that your plan lists alendronate at Tier 1. If it does not, use the Medicare plan finder at medicare.gov during open enrollment to switch to a plan where it is Tier 1. With the 2025 $2,000 annual out-of-pocket cap, even a Tier 2 placement rarely produces meaningful exposure [9].

Commercially insured patients. Ask your pharmacist to run the claim with a GoodRx coupon if the GoodRx price is lower than your copay. Pharmacists in Oregon are permitted to apply coupon pricing even for insured patients, and for a drug priced at $15 per month, the coupon price often beats a Tier 2 or Tier 3 copay. The Oregon Board of Pharmacy allows this practice as long as the claim is processed correctly [17].

Patients at safety-net clinics. Ask whether your clinic is a 340B-covered entity. If it is, your prescriber can route the prescription through the 340B program. Alendronate at 340B prices may cost the clinic under $5, and many 340B entities pass savings directly to patients [8].

Safety Considerations That Affect Long-Term Prescribing Decisions

Cost decisions should not be made in isolation from clinical context. Alendronate is generally safe for three to five years of continuous use. The American Society for Bone and Mineral Research task force recommends a drug holiday consideration after five years of oral bisphosphonate use, given the low but real risk of atypical femoral fracture (AFF) with extended therapy [18].

The absolute risk of AFF remains low. A 2011 NEJM analysis estimated AFF risk at 2.3 per 10,000 patient-years in women taking bisphosphonates for 2 to 3 years, rising to 13.0 per 10,000 patient-years after 8 or more years [19]. That risk must be weighed against the fracture risk from untreated osteoporosis, which for a 70-year-old Oregon woman with a T-score of -2.8 may exceed 25% over ten years per FRAX calculator estimates.

Osteonecrosis of the jaw (ONJ) is another rare adverse event associated with bisphosphonates, occurring at an estimated rate of 1 in 10,000 to 1 in 100,000 patient-years in patients taking oral bisphosphonates for osteoporosis (not the higher doses used in oncology) per the AAOMS 2022 position statement [20]. Patients scheduled for invasive dental procedures should inform their dentist of bisphosphonate use.

Alendronate is contraindicated in patients with esophageal abnormalities that delay transit, in those who cannot remain upright for 30 minutes, and in patients with creatinine clearance below 35 mL per minute. The FDA label specifies these contraindications in full [7].

Calcium and vitamin D adequacy must be confirmed before starting alendronate. The AACE 2020 guideline recommends 1,000 to 1 to 200 mg daily of elemental calcium (diet plus supplement) and 800 to 1 to 000 IU daily of vitamin D3 as the foundation of any pharmacologic osteoporosis regimen [2]. Calcium supplements taken within two hours of alendronate reduce alendronate absorption by up to 60%, per the prescribing information [7].

DXA Monitoring Intervals and When to Reassess Treatment in Oregon

Baseline DXA is required before starting alendronate. AACE recommends repeat DXA at 24 months after initiating therapy to assess response. A gain in bone mineral density of 2% to 3% at the lumbar spine or femoral neck is considered a meaningful response [2].

Oregon Medicare Part B covers DXA every 24 months for beneficiaries meeting clinical criteria under CPT code 77080. OHP covers DXA at baseline and at 24-month intervals for patients on active osteoporosis pharmacotherapy, subject to the ordering provider documenting clinical necessity [10]. Commercial insurers in Oregon generally follow the same 24-month interval, though some plans require prior authorization for repeat DXA.

If bone mineral density continues to decline despite two years of alendronate adherence, the clinical team should evaluate secondary causes of osteoporosis (hyperparathyroidism, vitamin D deficiency, malabsorption) before switching agents. The NEJM published a detailed review of secondary osteoporosis causes in 2021 (Shoback et al.) that is directly applicable to this decision [21].